SARS-CoV-2 neutralizing antibodies
4 papers study it2 findings
- Human trial1
- Humans3
Interventions
2SARS-COV-2 infection
upin humans1
1 study
SARS-COV-2 infection
upin humans1
SARS-COV-2 infection increases SARS-CoV-2 neutralizing antibodies in humans.
“humoral immune response analysis showed that these individuals displayed robust levels of IgG and neutralizing antibodies (NAbs) against SARS-CoV-2”
HumansCovid-19 in 2020 before being vaccinatedn = 3
The oldest unvaccinated Covid-19 survivors in South America
Immunity & ageing : I & ANov 16, 2022
Mrna COVID-19 vaccine
upin humans1
1 study
Mrna COVID-19 vaccine
upin humans1
Mrna COVID-19 vaccine increases SARS-CoV-2 neutralizing antibodies in humans.
“neutralising antibody responses were higher in Spikevax (Moderna) recipients, females, younger individuals and those with no underlying medical conditions”
Humansafter two vaccine doses
medRxivMay 30, 2022Preprint
Latest
1 paper in 12 monthsAging Cell
Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults-A Pilot Study
Randomized trial in 40 peopleSpermidine
NPJ Vaccines
Impact of ageing on homologous and human-coronavirus-reactive antibodies after SARS-CoV-2 vaccination or infection
Cohort study in peopleMechanisms
Immunity & Ageing
The oldest unvaccinated Covid-19 survivors in South America
Case series of 3 peopleMechanisms
medRxiv
SARS-CoV-2 neutralising antibody activity in a highly vaccinated population: Longitudinal serology studies in Singapore
Preprint: cohort study in peoplePopulations